BioPlan Associates presents research and projections on the pharma sterile fill-finish industry’s future over the next 10 ...

covering all stages of biologic drug development, from early clone selection and small-scale manufacturing through process scale-up, large-scale manufacturing, and quality control down to sterile ...

Navigating the sterile outsourcing bottleneck and how CDMOs must adapt to meet the growing demand for small-batch biologics and flexible fill-finish solutions. The sterile outsourcing industry is at a ...

exacerbated by the surge in demand for biologics and by the critical needs of the U.S. hospital supply chain. The Noramco Group’s investment will provide branded and generic pharmaceutical companies ...

ALBANY, N.Y., March 17, 2025 (GLOBE NEWSWIRE) -- Curia Global, Inc. (Curia), a leading contract research, development and manufacturing organization, today announced expansion plans to its Glasgow, UK ...

WOODSTOCK, Ill., March 11, 2025 (GLOBE NEWSWIRE) -- Woodstock Sterile Solutions, a leading blow-fill-seal (BFS) contract development and manufacturing organization (CDMO), is expanding its BFS ...

Leinco Technologies offers high-purity research-grade biosimilar antibodies with the same specifications as many therapeutic antibodies. Therapeutic antibodies are widely used for the treatment of ...

Our offerings in small molecule, generic APIs and biologics span discovery through commercialization, with integrated regulatory, analytical and sterile fill-finish capabilities. Our scientific ...